B-Complex Vitamin Injection Vials Recalled for Particulate Matter
AnazaoHealth is recalling B-Complex injection vials due to particulate matter contamination. Affected patients should discontinue use and consult their healthcare provider.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a risk-of-harm product (particulate matter in injectable medication). No illnesses or injuries have been reported in the source. Per the severity rubric, Class II recalls without reported hospitalization that present risk of harm are classified as High (score 3).
Plain-English summary
AnazaoHealth Corporation is recalling B-Complex vitamin injection vials nationwide due to the presence of particulate matter, which compromises the sterility required for injectable products.
The recall affects 5,707 vials distributed across the United States under NDC 72682-2230-3. Multiple lot numbers are affected, with expiration dates from February 2024 through March 2024.
Healthcare providers should immediately stop using affected vials. Patients who have received injections from recalled lots should contact their healthcare provider for appropriate guidance.
The recalled product
- Product
- B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3
- Manufacturer
- AnazaoHealth Corporation
- Category
- Drug — Vitamin Injection
- Affected units
- 5,707
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: 505075
- Exp: 02/05/24
- 505596
- Exp: 02/06/24
- 506155
- Exp: 02/07/24
- 508103
- Exp: 02/13/24
- 510837
- Exp: 02/19/24
- 512411
- Exp: 02/20/24
- 514856
- Exp: 02/25/24
- 515642
- Exp: 02/28/24
- 518309
- Exp: 03/05/24
- 524262
- 524266
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by AnazaoHealth Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · AnazaoHealth Corporation
See all →- HighFDA Recalls AnazaoHealth Injectable Vitamin Solution Due to Particulate Matter
FDA (Drugs) · 2024-01-03
- Severe
Same hazard · particulate matter
See all →- ModerateIMAAVY Injection Recalled for Presence of Particulate Matter
FDA (Drugs) · 2026-10-14
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls Plum Administration Sets Due to Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Similar recalls
- HighInjectable Vitamin B Vials Recalled for Particulate Matter Contamination
FDA (Drugs) · 2023-02-22
- HighInjectable vitamin B-complex products recalled for lack of sterility assurance
FDA (Drugs) · 2023-02-01
- HighVitamin B-Complex Injectable Vials Recalled for Lack of Sterility
FDA (Drugs) · 2022-07-20
- SeverePolymyxin B for Injection Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2022-02-16
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Vitamin B Complex Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-11-12